RE:RE:RE:Breakthrough status and IND applicationenriquesuave wrote: Think about it, if we get IND approval end of March or early April as originally expected, then we would get US trial sites approved very shortly after. That is at least hopefully 4 or more sites approved right away. They would normally start screening and enrolment within a month of approval so that would be in May. I think worst case is postponed in June if COVID is not yet enough under control. I personally believe it will be going to be much less of a threat in May-June and many potential COVID life saving treatments will be available by then. So we may just be delayed by about a month overall. Just IMO and let's hope there is no delay whatsoever by the time we are ready to stRt in the US.
The nugget of info that Theralase left out was crucial.
1. How many after the 12 treated are currently enrolled?
said another way
2. After suspending enrolling and treating.... how many are currently enrolled over 4 clinical sites awaiting treatment.. 2 more, 5 more, 10 more..
If Theralase said this.. we've treated 12 and 8 more are enrolled then we as shareholders know that we're at the finish line so to speak.